These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4300172)

  • 21. Temporal expression of pertussis toxin and Ptl secretion proteins by Bordetella pertussis.
    Rambow-Larsen AA; Weiss AA
    J Bacteriol; 2004 Jan; 186(1):43-50. PubMed ID: 14679223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Isolation of hemolytic cultures of Bordetella pertussis intended for the production of acellular pertussis preparations and the characterization of their biological properties].
    Miriasova LV; Vasnak'ian IA; Kopaeva TV; Remova TN; Kozhevnikova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):15-8. PubMed ID: 2552711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of methylated cyclodextrin on pertussis toxin accumulation in a Bordetella pertussis culture in a bioreactor].
    Siundiukova RA; Basnak'ian IA; Stukalova NV; Aleksakhina NN
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):14-7. PubMed ID: 10876840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Pertussis Toxin Expression in B2 and THIJS Media.
    Moradtalab H; Noofeli M; Zeighami H; Haghi F
    Arch Razi Inst; 2019 Mar; 74(1):59-67. PubMed ID: 31013007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of heptakis (2,6-O-dimethyl) beta-cyclodextrin on the production of pertussis toxin by Bordetella pertussis.
    Imaizumi A; Suzuki Y; Ono S; Sato H; Sato Y
    Infect Immun; 1983 Sep; 41(3):1138-43. PubMed ID: 6309661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative toxicity, protective, histamine sensitizing and leucocytosis promoting activities in mice of Bordetella pertussis culture fluid, bacterial cells and cell extracts.
    Megret F; Fournier JM; Alouf JE
    Med Microbiol Immunol; 1984; 173(4):225-32. PubMed ID: 6096686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The cultivation of Bordetella pertussis under different conditions and a study of the cultures obtained].
    Nikolaeva VB; Roshchupkina MN; Gruber IM; Sviridov VV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):13-4. PubMed ID: 7661907
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibacterial agents and release of periplasmic pertussis toxin from Bordetella pertussis.
    Craig-Mylius KA; Weiss AA
    Antimicrob Agents Chemother; 2000 May; 44(5):1383-6. PubMed ID: 10770786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antigenic activity of Bordetella pertussis during cultivation in liquid nutrient media].
    Miriasova LV; Moshiashvili IIa; Basnak'ian IA; Sergeev VV; Zaporozhtsev LN
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jun; (6):31-6. PubMed ID: 209647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison between two types of pertussis vaccines].
    Bisaillon JG
    Rev Can Biol; 1977 Sep; 36(3):283-9. PubMed ID: 200987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of purified components of Bordetella pertussis in the weight gain test for the toxicity testing of pertussis vaccines.
    Redhead K; Seagroatt V
    J Biol Stand; 1986 Jan; 14(1):57-65. PubMed ID: 2870067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cultivation of Bordetella pertussis in liquid semisynthetic nutrient media with ion-exchange resins].
    Sukhinova EE; Shmeleva EI; Mertsalova NU; Iulin II; Golshmid VK
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):64-7. PubMed ID: 6277111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved pertussis toxin production by Bordetella pertussis through adjusting the growth medium's ionic composition.
    Frohlich BT; De Bernardez Clark ER; Siber GR; Swartz RW
    J Biotechnol; 1995 May; 39(3):205-19. PubMed ID: 7766402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Release of lipopolysaccharide during Bordetella pertussis growth.
    Hozbor D; Rodriguez ME; Samo A; Lagares A; Yantorno O
    Res Microbiol; 1993; 144(3):201-9. PubMed ID: 8210677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CHEMICAL STUDIES ON CELLULAR COMPONENTS OF BORDETELLA PERTUSSIS. III. ISOLATION OF HIGHLY POTENT TOXIN FROM BORDETELLA PERTUSSIS.
    ONOUE K; KITAGAWA M; YAMAMURA Y
    J Bacteriol; 1963 Oct; 86(4):648-55. PubMed ID: 14066457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of humoral, cellular and non-specific immunity on intracerebral Bordetella pertussis infections in mice.
    Dolby JM; Dolby DE; Bronne-Shanbury CJ
    J Hyg (Lond); 1975 Feb; 74(1):85-102. PubMed ID: 163275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunogenicity and safety of vaccine preparations based on circulating Bordetella pertussis strains].
    Zaĭtsev EM; Mertsalova NIu; Britsina MV; Ozeretskovskaia MN; Bazhanova IG; Shinkarev AS; Poddubikov AV
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (4):18-22. PubMed ID: 25286523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lethal infection by Bordetella pertussis mutants in the infant mouse model.
    Weiss AA; Goodwin MS
    Infect Immun; 1989 Dec; 57(12):3757-64. PubMed ID: 2572561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cell components of Bordetella pertussis and their biological activities].
    Sato Y; Arai H
    Tanpakushitsu Kakusan Koso; 1972; 17(2):139-49. PubMed ID: 4337077
    [No Abstract]   [Full Text] [Related]  

  • 40. Bordetella pertussis adenylate cyclase toxin: intoxication of host cells by bacterial invasion.
    Mouallem M; Farfel Z; Hanski E
    Infect Immun; 1990 Nov; 58(11):3759-64. PubMed ID: 2172167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.